Nanoengineered polymers and other organic materials in lung cancer treatment: Bridging the gap between research and clinical applications

Simple item page
dc.citation.volume208
dc.contributor.authorJin X
dc.contributor.authorHeidari G
dc.contributor.authorHua Z
dc.contributor.authorLei Y
dc.contributor.authorHuang J
dc.contributor.authorWu Z
dc.contributor.authorPaiva-Santos AC
dc.contributor.authorGuo Z
dc.contributor.authorKarimi Male H
dc.contributor.authorNeisiany RE
dc.contributor.authorSillanpää M
dc.contributor.authorPrakash C
dc.contributor.authorWang X
dc.contributor.authorTan Y
dc.contributor.authorMakvandi P
dc.contributor.authorXu Y
dc.date.accessioned2024-07-30T02:47:12Z
dc.date.available2024-07-30T02:47:12Z
dc.date.issued2024-03-25
dc.description.abstractCancer remains a major global health challenge, with increasing incidence and mortality rates projected for the coming years. Lung cancer, in particular, poses significant obstacles due to late-stage diagnosis and limited treatment options. While advancements in molecular diagnostics have been made, there is a critical need to connect the dots between laboratory and hospital for better lung cancer treatment. Systemic therapy plays a crucial role in treating advanced-stage lung cancer, and recent efforts have focused on developing innovative drug delivery techniques. Nanoparticles (NPs) have emerged as a promising approach to lung cancer treatment, offering enhanced drug delivery, active targeting, and reduced toxicity. Organic-based nanomaterials, like polymeric nanoparticles, solid lipid nanoparticles, and liposomes hold great potential in this field. This review examines the application of NPs in lung cancer treatment, highlights current therapies, explores organic nanoparticle-based approaches, and discusses limitations and future perspectives in clinical translation.
dc.description.confidentialfalse
dc.identifier.citationJin X, Heidari G, Hua Z, Lei Y, Huang J, Wu Z, Cláudia Paiva-Santos A, Guo Z, Karimi Male H, Neisiany RE, Sillanpää M, Prakash C, Wang X, Tan Y, Makvandi P, Xu Y. (2024). Nanoengineered polymers and other organic materials in lung cancer treatment: Bridging the gap between research and clinical applications. European Polymer Journal. 208.
dc.identifier.doi10.1016/j.eurpolymj.2024.112891
dc.identifier.eissn1873-1945
dc.identifier.elements-typejournal-article
dc.identifier.issn0014-3057
dc.identifier.number112891
dc.identifier.piiS0014305724001526
dc.identifier.urihttps://mro.massey.ac.nz/handle/10179/71151
dc.languageEnglish
dc.publisherElsevier Ltd
dc.publisher.urihttps://www.sciencedirect.com/science/article/pii/S0014305724001526
dc.relation.isPartOfEuropean Polymer Journal
dc.rights(c) 2024 The Author/s
dc.rightsCC BY 4.0
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectCancer
dc.subjectLung
dc.subjectBiomedical
dc.subjectNanoparticles
dc.titleNanoengineered polymers and other organic materials in lung cancer treatment: Bridging the gap between research and clinical applications
dc.typeJournal article
pubs.elements-id487605
pubs.organisational-groupOther
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Published version.pdf
Size:
12.22 MB
Format:
Adobe Portable Document Format
Description:
487605 PDF.pdf
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
9.22 KB
Format:
Plain Text
Description:
Download
Collections
Journal Articles